Biotech entity
pharma is the sole category represented across all 1 tracked stories. GOOD Vision oka³y ! ™ is most often covered alongside Geneva, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention GOOD Vision oka³y ! ™, all published on March 9, 2026.
Last mentioned: Mar 9, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. GOOD Vision oka³y ! ™ is most often covered alongside Geneva, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention GOOD Vision oka³y ! ™, all published on March 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering GOOD Vision oka³y ! ™. Shared-story counts are live from our verified record — not editorial picks.
Global Debut
Official unveiling of the technology at the Geneva innovation showcase.
Prototype Testing
Initial testing of the GOOD Vision oka³y ! ™ lens system for fitting accuracy.
Research & Algorithm Development
PolyU researchers refine freeform algorithms for corneal topography mapping.
The Hong Kong Polytechnic University (PolyU) has introduced GOOD Vision oka³y ! ™, a breakthrough freeform orthokeratology lens system, at its global debut in Geneva. This technology represents a significant leap in myopia management, offering sub-micron precision for personalized corneal reshaping.
GOOD Vision oka³y ! ™ is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
